Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease ...
Agios Pharmaceuticals Inc. is learning the hard way the downside of having a pipeline in a product. When a side effect crops up, investors are likely to worry that it may affect the potential of the ...
Odronextamab monotherapy led to complete responses in all patients with previously untreated follicular lymphoma evaluable for efficacy, per initial results from the safety lead-in portion of the conf ...
Hepatitis, an inflammation of the liver caused by viral infections or other factors, remains a significant global health ...
With the help of an AI tool, computed tomography (CT) scans taken originally to look for tumors or bleeding or infections, also revealed calcium buildup in arteries, a sign of worsening cardiovascular ...
A bill filed in the State House aims to protect the rights of patients going through treatment in Oklahoma hospitals.
Researchers at Karolinska Institutet and the University of Gothenburg have identified two types of metabolic-associated fatty ...
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease ...
For those dealing with fatty liver disease, there’s welcome news to report. Earlier this year, the United States Food and ...
The Environmental Protection Agency (EPA) has banned trichloroethylene (TCE) and perchloroethylene (Perc), two commonly used ...
Paltusotine was granted Orphan Drug Designation for the treatment of acromegaly by the FDA in July 2020. This designation is provided to drugs defined as being intended for the safe and effective ...
Up to one in 10 pregnancies in the developed world are affected by placental growth restriction, and twice that in the ...